BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Willicombe M, Thomas D, McAdoo S. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J Am Soc Nephrol. 2020;31:1145-1146. [PMID: 32312797 DOI: 10.1681/asn.2020030348] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
2 Kataria A, Yakubu I, Winstead R, Gowda M, Gupta G. COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice. Transplant Direct 2020;6:e582. [PMID: 33134506 DOI: 10.1097/TXD.0000000000001031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
3 Hasbal NB, Turgut D, Gok Oguz E, Ulu S, Gungor O. Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients. Ann Transplant 2021;26:e929279. [PMID: 33707409 DOI: 10.12659/AOT.929279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Patel D, Truong T, Shah N, Colbert GB, Thomas B, Velez JCQ, Lerma EV, Hiremath S. COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care. Dis Mon 2020;66:101057. [PMID: 32758363 DOI: 10.1016/j.disamonth.2020.101057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, Lladó L, Caballero A, Fernández-Yunquera A, Loinaz C, Fernández I, Fondevila C, Navasa M, Iñarrairaegui M, Castells L, Pascual S, Ramírez P, Vinaixa C, González-Dieguez ML, González-Grande R, Hierro L, Nogueras F, Otero A, Álamo JM, Blanco-Fernández G, Fábrega E, García-Pajares F, Montero JL, Tomé S, De la Rosa G, Pons JA. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol 2021;74:148-55. [PMID: 32750442 DOI: 10.1016/j.jhep.2020.07.040] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 38.0] [Reference Citation Analysis]
6 Rammohan A. Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing. World J Transplant 2020; 10(9): 267-276 [PMID: 32995321 DOI: 10.5500/wjt.v10.i9.267] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Esagian SM, Ziogas IA, Giannis D, Hayat MH, Elias N, Tsoulfas G. Challenges in Abdominal Organ Transplantation During the COVID-19 Pandemic. Front Med (Lausanne) 2020;7:287. [PMID: 32582741 DOI: 10.3389/fmed.2020.00287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
8 Kullar R, Patel AP, Saab S. COVID-19 in Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:545-50. [PMID: 34447684 DOI: 10.14218/JCTH.2020.00098] [Reference Citation Analysis]
9 Alkadi MM, Al-Malki HA, Asim M, Fituri OM, Hamdi AF, Elidrisi RI, Abdul Rahiman R, Elshirbeny MF, Othman MA, Nauman A, Ashour A, Ghonimi TA, Tohid H, Jarman ME, Hamad A, Elshazly MB, Abuhelaiqa E. Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience. Transplant Proc 2021:S0041-1345(21)00405-X. [PMID: 34275597 DOI: 10.1016/j.transproceed.2021.06.001] [Reference Citation Analysis]
10 Masset C, Gautier-vargas G, Cantarovich D, Dantal J, Delbos F, Walencik A, Kerleau C, Hourmant M, Garandeau C, Meurette A, Giral M, Benotmane I, Caillard S, Blancho G. Occurrence of de novo Donor Specific Antibodies after Covid-19 in kidney transplant recipients is low despite immunosuppression modulation. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1072] [Reference Citation Analysis]
11 Daoud A, Alqassieh A, Alkhader D, Posadas Salas MA, Rao V, Fülöp T, Soliman KM. Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? Ren Fail 2021;43:273-80. [PMID: 33491531 DOI: 10.1080/0886022X.2021.1876730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tavares MS, Penido MGMG, Andrade OVB, Koch VHK, Bernardes RP, Garcia CD, Moura-Neto JA, Nascimento MM, Palma LMP. Recommendations Of The Brazilian Society Of Nephrology Regarding Pediatric Patients On Renal Replacement Therapy During The Covid-19 Pandemic.J Bras Nefrol. 2020;42:32-35. [PMID: 32877496 DOI: 10.1590/2175-8239-JBN-2020-S108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Waldman M, Soler MJ, García-Carro C, Lightstone L, Turner-Stokes T, Griffith M, Torras J, Valenzuela LM, Bestard O, Geddes C, Flossmann O, Budge KL, Cantarelli C, Fiaccadori E, Delsante M, Morales E, Gutierrez E, Niño-Cruz JA, Martinez-Rueda AJ, Comai G, Bini C, La Manna G, Slon MF, Manrique J, Agraz I, Sinaii N, Cravedi P. Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. Kidney Int 2021;99:227-37. [PMID: 33181156 DOI: 10.1016/j.kint.2020.10.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
14 Wan ER, Unwin R, Walsh SB. COVID-19 2020: The Experience of a London Teaching Hospital's Nephrology Service. Kidney Blood Press Res 2021;46:137-41. [PMID: 33823516 DOI: 10.1159/000515194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dedinská I, Skálová P, Graňák K, Vnučák M, Baltesová T, Žilinská Z, Jeseňák M. The Role of HLA Antigens and Steroid Dose on the Course of COVID-19 of Patients After Kidney Transplantation. Front Med (Lausanne) 2021;8:730156. [PMID: 34790673 DOI: 10.3389/fmed.2021.730156] [Reference Citation Analysis]
16 Oguz EG, Atilgan KG, Cimen SG, Sahin H, Selen T, Ebinc FA, Cimen S, Ayli MD. COVID-19 infection in a kidney transplant recipient—special emphasis on pharmacokinetic interactions: A case report. World J Transplant 2020; 10(11): 365-371 [PMID: 33312897 DOI: 10.5500/wjt.v10.i11.365] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Dittmar M, Lee JS, Whig K, Segrist E, Li M, Kamalia B, Castellana L, Ayyanathan K, Cardenas-Diaz FL, Morrisey EE, Truitt R, Yang W, Jurado K, Samby K, Ramage H, Schultz DC, Cherry S. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep 2021;35:108959. [PMID: 33811811 DOI: 10.1016/j.celrep.2021.108959] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 27.0] [Reference Citation Analysis]
18 Demir E, Uyar M, Parmaksiz E, Sinangil A, Yelken B, Dirim AB, Merhametsiz O, Yadigar S, Atan Ucar Z, Ucar AR, Demir ME, Mese M, Akin EB, Garayeva N, Safak S, Oto OA, Yazici H, Turkmen A. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul. Transpl Infect Dis 2020;22:e13371. [PMID: 32657540 DOI: 10.1111/tid.13371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
19 Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, Thaunat O, Legris T, Moal V, Westeel PF, Kamar N, Gatault P, Snanoudj R, Sicard A, Bertrand D, Colosio C, Couzi L, Chemouny JM, Masset C, Blancho G, Bamoulid J, Duveau A, Bouvier N, Chavarot N, Grimbert P, Moulin B, Le Meur Y, Hazzan M; French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98:1549-58. [PMID: 32853631 DOI: 10.1016/j.kint.2020.08.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 34.0] [Reference Citation Analysis]
20 Teoh CW, Gaudreault-Tremblay MM, Blydt-Hansen TD, Goldberg A, Arora S, Feber J, Langlois V, Ruhl M, Phan V, Morgan C, Acott P, Hamiwka L. Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group. Can J Kidney Health Dis 2020;7:2054358120967845. [PMID: 33240516 DOI: 10.1177/2054358120967845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
21 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
22 Campbell CM, Guha A, Haque T, Neilan TG, Addison D. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review. J Clin Med 2020;9:E2935. [PMID: 32932930 DOI: 10.3390/jcm9092935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 AlOtaibi TM, Gheith OA, Abuelmagd MM, Adel M, Alqallaf AK, Elserwy NA, Shaker M, Abbas AM, Nagib AM, Nair P, Halim MA, Mahmoud T, Khaled MM, Hammad MA, Fayyad ZA, Atta AF, Mostafa AY, Draz AS, Zakaria ZE, Atea KA, Aboatya HH, Ameenn ME, Monem MA, Mahmoud AM. Better outcome of COVID-19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression. Clin Transplant 2021;35:e14297. [PMID: 33768630 DOI: 10.1111/ctr.14297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Freitas AF, Pugliese RPS, Feier F, Miura IK, Danesi VLB, Oliveira EN, Hirschfeld APM, Borges CBV, Lobato JV, Porta G, Seda-neto J, Fonseca EA. Impact of COVID-19 Infection on Children and Adolescents after Liver Transplantation in a Latin American Reference Center. Microorganisms 2022;10:1030. [DOI: 10.3390/microorganisms10051030] [Reference Citation Analysis]
25 Alshami A, Al Attas R, Azzam A, Mohammed A, Al-Quhaidan N. Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients. BMC Nephrol 2021;22:123. [PMID: 33827461 DOI: 10.1186/s12882-021-02325-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kant S, Menez SP, Hanouneh M, Fine DM, Crews DC, Brennan DC, Sperati CJ, Jaar BG. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol 2020;21:449. [PMID: 33109103 DOI: 10.1186/s12882-020-02112-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
27 Lubetzky M, Aull MJ, Craig-Schapiro R, Lee JR, Marku-Podvorica J, Salinas T, Gingras L, Lee JB, Sultan S, Kodiyanplakkal RP, Hartono C, Saal S, Muthukumar T, Kapur S, Suthanthiran M, Dadhania DM. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center. Nephrol Dial Transplant 2020;35:1250-61. [PMID: 32678882 DOI: 10.1093/ndt/gfaa154] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
28 Farouk SS, Fiaccadori E, Cravedi P, Campbell KN. COVID-19 and the kidney: what we think we know so far and what we don't. J Nephrol 2020;33:1213-8. [PMID: 32691342 DOI: 10.1007/s40620-020-00789-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
29 Kakos CD, Ziogas IA, Tsoulfas G. Pediatric transplantation during the COVID-19 pandemic. World J Transplant 2022; 12(5): 88-99 [DOI: 10.5500/wjt.v12.i5.88] [Reference Citation Analysis]
30 Karruli A, Spiezia S, Boccia F, Gagliardi M, Patauner F, Salemme A, Maiello C, Zampino R, Durante-Mangoni E. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis. Transpl Infect Dis 2021;:e13595. [PMID: 33641202 DOI: 10.1111/tid.13595] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Robinson C, Ruhl M, Kirpalani A, Alabbas A, Noone D, Teoh CW, Langlois V, Phan V, Lemaire M, Chanchlani R. Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team. Can J Kidney Health Dis 2020;7:2054358120970713. [PMID: 33240518 DOI: 10.1177/2054358120970713] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Clarke C, Lucisano G, Prendecki M, Gleeson S, Martin P, Ali M, McAdoo SP, Lightstone L, Ashby D, Charif R, Griffith M, McLean A, Dor F, Willicombe M; ICHNT Renal COVID Group. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep 2021;6:46-55. [PMID: 33173838 DOI: 10.1016/j.ekir.2020.10.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Sarrell BA, Bloch K, El Chediak A, Kumm K, Tracy K, Forbes RC, Langone A, Thomas L, Schlendorf K, Trindade AJ, Perri R, Wright P, Concepcion BP. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients. Transpl Infect Dis 2021;:e13759. [PMID: 34787345 DOI: 10.1111/tid.13759] [Reference Citation Analysis]
34 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Hage R, Steinack C, Gautschi F, Schuurmans MM. Transplant Drugs against SARS, MERS and COVID-19. Transplantology 2020;1:71-84. [DOI: 10.3390/transplantology1020007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
36 Guella A, Elfadil O, Abdulrazaq G, Osman S, Khan MM, Ahmed A, Deyab F. Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab. Case Rep Infect Dis 2020;2020:8830626. [PMID: 32963854 DOI: 10.1155/2020/8830626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Tuli HS, Sood S, Kaur J, Kumar P, Seth P, Punia S, Yadav P, Sharma AK, Aggarwal D, Sak K. Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements. 3 Biotech 2021;11:110. [PMID: 33552835 DOI: 10.1007/s13205-021-02644-8] [Reference Citation Analysis]
38 Dheir H, Sipahi S, Yaylacı S, Çetin ES, Genç AB, Fırat N, Köroğlu M, Muratdağı G, Tomak Y, Özmen K, Ateş ÖF, Karabay O. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients. Turk J Med Sci 2021;51:428-34. [PMID: 33185367 DOI: 10.3906/sag-2007-260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]
40 Koc NS, Yildirim T, Saglam A, Arici M, Erdem Y. A patient with COVID-19 and anti-glomerular basement membrane disease. Nefrología (English Edition) 2021;41:471-3. [DOI: 10.1016/j.nefroe.2021.08.008] [Reference Citation Analysis]